z-logo
open-access-imgOpen Access
Prognostic impact of MutT homolog‐1 expression on esophageal squamous cell carcinoma
Author(s) -
Akiyama Shingo,
Saeki Hiroshi,
Nakashima Yuichiro,
Iimori Makoto,
Kitao Hiroyuki,
Oki Eiji,
Oda Yoshinao,
Nakabeppu Yusaku,
Kakeji Yoshihiro,
Maehara Yoshihiko
Publication year - 2017
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.979
Subject(s) - cancer research , immunohistochemistry , transcription factor , biology , cancer , deoxyguanosine , oxidative stress , gene , immunology , endocrinology , biochemistry , genetics
MutT homolog‐1 ( MTH 1) is a pyrophosphatase that acts on oxidized nucleotides and hydrolyzes 8‐oxo‐2’‐deoxyguanosine triphosphate in deoxynucleoside triphosphate pool to prevent its incorporation into nuclear and mitochondrial DNA , result in reduce cytotoxicity in tumor cells. MTH 1 is overexpressed in various cancers and is considered as a therapeutic target. Environmental factors such as cigarette smoking and alcohol consumption are critical risk factors for the development and progression of esophageal squamous cell carcinoma ( ESCC ), suggesting that oxidative stress contributes to the pathogenesis of ESCC . We examined the expression of MTH 1 and the accumulation of 8‐oxo‐2’‐deoxyguanosine (8‐oxo‐ dG ) in 84 patients with ESCC who underwent curative resection without neoadjuvant therapy. MTH 1 mRNA level was quantified by performing quantitative reverse transcription‐ PCR . Immunohistochemical analysis of paraffin‐embedded cancer tissues was performed to determine MTH 1 protein expression and 8‐oxo‐ dG accumulation. MTH 1 mRNA expression was higher in cancerous tissues than in the corresponding normal epithelium ( P  < 0.0001). Immunohistochemical analysis showed that high MTH 1 expression was significantly associated with deeper tumor invasion and venous invasion, advanced cancer stage, and poor overall survival ( P  = 0.0021) and disease‐specific survival ( P  = 0.0013) compared with low MTH 1 expression. Furthermore, high MTH 1 expression was an independent predictor of poor disease‐specific survival ( P  = 0.0121). In contrast, 8‐oxo‐ dG accumulation was not associated with any clinicopathological factor and poor prognosis. These results suggest that MTH 1 overexpression is a predictor of ESCC progression and poor prognosis and that MTH 1 can serve as a therapeutic target for treating patients with ESCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here